The influence of genetic variants may affect this relationship.
The presence of genetic variants may have implications for therapeutic approaches in MS patients.
These drug-resistant variants may then multiply and come to predominate in the intestines and elsewhere in the body.
But some population-specific variants may exist, and a population could fail to benefit if the variant is not detected.
Also, variants may affect biochemical functions that contribute to cancer susceptibility but are not being interrogated by the assay.
It is likely that these abnormal splicing variants may not translate into functional resistance proteins based on previous studies35,36.
As well as overall risk, certain gene variants may also correlate with particular presentations of IBD, Ananthakrishnan says.
Ye, N. et al. Intergenic variants may predispose to major depression disorder through regulation of long non-coding RNA expression.
These variants may be due to changing manufacturing conditions, temperature, voltage, and other variables.
Natural polymorphisms and alternative splice variants may also contribute to their pharmacological diversity.
Genetic variants may modulate dopamine transporter (DAT) availability in the brain.
